Diabetes Information

  • Diabetes Educators Slider

    We believe: The greatest solutions arise from collaboration.

    Evidence + Judgment = Best Care

    Start Here

Latest Updates

Some of your patients may be switched from Lantus to Basalgar in the upcoming year. The Alberta Biosimilars initiative will impact those on Alberta Goverment sponsored drug programs (not Blue Cross group or individual plans). Patients on glargine (Lantus) will be required to switch to glargine (Basaglar) for cost savings by June 30, 2020. Read more here

Diabetes Update Sign-Up

Stay up-to-date with diabetes education and management. Receive updates on new medications, products, continuing education for healthcare professionals and more by signing up for our periodic emails.

To view past updates, please visit our archives.